Lynn Lewis has been appointed senior vice president, Global Sales, Envigo. She brings both science and business experience having held pharmaceutical and leadership roles within sales and operations in the CRO industry. This new role was created to strengthen the company’s position in the marketplace with a focus on continuing to provide outstanding customer service. Lynn will report to Craig Boyd, Envigo’s chief commercial officer.

Most recently, Ms. Lewis was group vice president of business development, Clinical Development and Commercialization Services for Covance. During her 15-year career with Covance, she also led the global sales organizations for the nonclinical and central laboratory businesses and served as the general manager of Covance’s drug discovery and development campus in Greenfield, IN. Before joining Covance, she worked for Eli Lilly and Co. leading cross functional development teams to bring new medicines to market.  

“Given the dynamic growth in the CRO industry, there is an increasing opportunity to further engage our existing customers, as well as attract emerging life sciences companies to Envigo’s non-clinical service offerings and research products. We are thrilled that Lynn Lewis has joined our team to drive this important effort,” said Dr. Adrian Hardy, president and chief executive officer. “Lynn’s broad experience leading serving the biopharmaceutical industry will be an invaluable asset to our commercial team. Under her guidance, our sales teams in North America, Europe and Asia Pacific will be unified to provide additional focus on enterprise-wide growth initiatives.”